Dare Bioscience (DARE) Interest Coverage Ratio: History & Chart

Dare Bioscience, Inc.(DARE)

Biotechnology · San Diego, CA

$0.83-0.01 (-1.36%)

Delayed quote: Oct 6, 2026, 10:23 AM EDT

About Dare Bioscience, Inc.

Daré Bioscience, Inc. develops therapies in the areas of contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in the United States. The company offers XACIATO, a lincosamide antibacterial gel for the treatment of bacterial vaginosis. It also develops Ovaprene, a hormone-free monthly intravaginal contraceptive; Sildenafil Cream, a cream formulation of sildenafil for topical administration to the female genitalia for the treatment of female sexual arousal disorder; DARE-HRT1 to treat vasomotor symptoms in menopausal hormone therapy; DARE-VVA1 for the treatment of dyspareunia or pain during sexual intercourse; and DARE-HPV, a fixed-dose formulation of lopinavir and ritonavir in a soft gel vaginal insert to treat genital human papillomavirus (HPV) infection, cervical intraepithelial neoplasia, and other HPV-related pathologies. In addition, the company develops DARE-PDM1, a hydrogel formulation of diclofenac for vaginal administration to treat primary dysmenorrhea; DARE-204 and DARE-214, injectable formulations of etonogestrel that provides contraception over 6-month and 12-month periods; DARE-FRT1, an intravaginal ring designed to deliver bio-identical progesterone for luteal phase support as part of an in vitro fertilization treatment plan; and DARE-PTB1 for the prevention of preterm birth. Further, it develops DARE-LARC1, a contraceptive implant delivering levonorgestrel with a woman-centered design controlled contraceptive option; DARE-RH1, an approach to non-hormonal contraception for men and women by targeting the CatSper ion channel; DARE-PTB2 for the prevention and treatment of idiopathic preterm birth through inhibition of a stress response protein; DARE-LBT, a vaginal thermosetting gel formulation for the delivery of live biotherapeutics; and DARE-GML, which delivers antimicrobial glycerol monolaurate intravaginally. Daré Bioscience, Inc. was founded in 2015 and is headquartered in San Diego, California.

San Diego, CA

23 employees

darebioscience.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Sabrina Martucci Johnson

View full financials

DARE Interest Coverage Ratio Metrics

INTEREST COVERAGE RATIO

-16.47x

INTEREST COVERAGE RATIO AVG TTM

-14.65x

INTEREST COVERAGE RATIO AVG 3Y

-14.65x

INTEREST COVERAGE RATIO AVG 5Y

-14.65x

INTEREST COVERAGE RATIO AVG 10Y

-144.52x

INTEREST COVERAGE RATIO AVG 15Y

N/A

INTEREST COVERAGE RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

-12.44%

CURRENT VS 3Y AVG

-12.44%

CURRENT VS 5Y AVG

-12.44%

CURRENT VS 10Y AVG

+88.60%

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

-4.67x

median of 372 covered companies

CURRENT VS SECTOR MEDIAN

-253.05%

vs the sector median at left

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
Dare Bioscience, Inc. (DARE)	$12.46M	-16.47x	-14.65x	-14.65x	-14.65x
IRIDEX Corporation (IRIX)vs ›	$12.41M	N/A	4.58x	5.23x	12.43x
Lantern Pharma Inc. (LTRN)vs ›	$11.87M	N/A	N/A	N/A	N/A
Cellectar Biosciences, Inc. (CLRB)vs ›	$13.06M	N/A	N/A	N/A	N/A
Cytosorbents Corporation (CTSO)vs ›	$11.85M	-5.45x	0.92x	0.92x	0.92x
Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs ›	$11.50M	-1171.55x	N/A	N/A	N/A
Vyome Holdings, Inc. (HIND)vs ›	$13.41M	-18.73x	N/A	N/A	N/A
Adial Pharmaceuticals, Inc. (ADIL)vs ›	$11.50M	N/A	N/A	N/A	N/A
Lisata Therapeutics, Inc. (LSTA)vs ›	$11.38M	N/A	N/A	N/A	N/A
Biofrontera Inc. (BFRI)vs ›	$11.09M	-20.24x	N/A	N/A	N/A

NAME

MARKET CAP

INTEREST COVERAGE RATIO

TTM

Dare Bioscience, Inc. (DARE)

$12.46M

-16.47x

-14.65x

IRIDEX Corporation (IRIX)vs ›

$12.41M

N/A

4.58x

5.23x

12.43x

Lantern Pharma Inc. (LTRN)vs ›

$11.87M

N/A

Cellectar Biosciences, Inc. (CLRB)vs ›

$13.06M

N/A

Cytosorbents Corporation (CTSO)vs ›

$11.85M

-5.45x

0.92x

Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs ›

$11.50M

-1171.55x

N/A

Vyome Holdings, Inc. (HIND)vs ›

$13.41M

-18.73x

N/A

Adial Pharmaceuticals, Inc. (ADIL)vs ›

$11.50M

N/A

Lisata Therapeutics, Inc. (LSTA)vs ›

$11.38M

N/A

Biofrontera Inc. (BFRI)vs ›

$11.09M

-20.24x

N/A

Interest Coverage Ratio FAQ

What is the interest coverage ratio for Dare Bioscience, Inc. (DARE)?

The interest coverage ratio for DARE stock is -16.47x.

Is Dare Bioscience, Inc.'s interest coverage ratio high or low?

The interest coverage ratio of -16.47x is 12% below its 1-year average of -14.65x, near the low end of its 1-year range (-16.47x–-14.25x).

What is the TTM average interest coverage ratio for Dare Bioscience, Inc. (DARE)?

The TTM average interest coverage ratio for DARE stock is -14.65x.

What is the 3Y average interest coverage ratio for Dare Bioscience, Inc. (DARE)?

The 3Y average interest coverage ratio for DARE stock is -14.65x.

What is the 5Y average interest coverage ratio for Dare Bioscience, Inc. (DARE)?

The 5Y average interest coverage ratio for DARE stock is -14.65x.

What is the 10Y average interest coverage ratio for Dare Bioscience, Inc. (DARE)?

The 10Y average interest coverage ratio for DARE stock is -144.52x.

DATE	INTEREST COVERAGE RATIO
2026-03-31	-15.04x
2025-06-30	-14.25x
2017-12-31	-1201.87x
2017-09-30	-4.50x
2017-03-31	-0.29x
2016-12-31	-9.89x
2016-09-30	-18.16x
2016-06-30	-17.24x
2016-03-31	-19.44x
2015-12-31	-14.73x
2015-09-30	-19.74x
2015-06-30	-18.31x
2015-03-31	-10.68x
2014-12-31	-44.83x
2014-09-30	-28.11x
2014-06-30	-17.33x
2014-03-31	-6.42x
2013-12-31	-7.00x
2013-09-30	-7.44x
2013-06-30	-14.07x
2013-03-31	-15.44x

DATE

INTEREST COVERAGE RATIO

2026-03-31

-15.04x

2025-06-30

-14.25x

2017-12-31

-1201.87x

2017-09-30

-4.50x

2017-03-31

-0.29x

2016-12-31

-9.89x

2016-09-30

-18.16x

2016-06-30

-17.24x

2016-03-31

-19.44x

2015-12-31

-14.73x

2015-09-30

-19.74x

2015-06-30

-18.31x

2015-03-31

-10.68x

2014-12-31

-44.83x

2014-09-30

-28.11x

2014-06-30

-17.33x

2014-03-31

-6.42x

2013-12-31

-7.00x

2013-09-30

-7.44x

2013-06-30

-14.07x

2013-03-31

-15.44x

Interest Coverage Ratio: -16.47x

DARE Interest Coverage Ratio

DARE Average Interest Coverage Ratio Chart

DARE Current vs Average Interest Coverage Ratio Chart

DARE Interest Coverage Ratio Metrics

DARE Competitors' Interest Coverage Ratio

Financial Health Indicators

Interest Coverage Ratio Formula & Definition

Interest Coverage Ratio FAQ

DARE Interest Coverage Ratio History

Related Metrics